Literature DB >> 20186945

Fistula-associated anal adenocarcinoma in Crohn's disease.

Igors Iesalnieks1, Wolfgang B Gaertner, Heidi Glass, Ulrike Strauch, Matthias Hipp, Ayman Agha, Hans J Schlitt.   

Abstract

BACKGROUND: Adenocarcinoma arising from perianal fistulae in patients with Crohn's disease (CD) is rare. The literature consists mainly of case reports and small series making characterization of this clinical entity difficult. We present 6 patients with CD and fistula-associated anal adenocarcinoma (FAAA) and a systematic review of published series.
METHODS: Retrospective charts were reviewed of 6 consecutive patients with FAAA in CD treated from 1992 through 2007. All available variables of our patients and of all available published cases were included for statistical analysis.
RESULTS: All patients treated at our institution had severe perianal CD at presentation. The average age at time of diagnosis was 45.5 years. All patients underwent abdominoperineal resection (APR) and 4 received chemoradiation. Four patients died with metastatic disease, 1 is alive with pelvic recurrence at 55 months, and 1 is alive without evidence of disease at 19 months follow-up. A total of 23 publications including 65 patients (37 female, mean age 53 years) with FAAA were reviewed in our systematic review. The average fistula duration was 14 years. Mean delay of cancer diagnosis was 11 months. APR was performed in 56 patients with an overall 3-year survival rate of 54%. Thirteen of 15 patients with node-positive tumors died with recurrent disease following surgery.
CONCLUSIONS: Adenocarcinoma arising from long-standing perianal CD fistulae is being increasingly reported. The outcome is poor following operative treatment, especially if perirectal lymph nodes are involved. Periodical cancer surveillance should be performed in all patients with long-standing perianal CD fistulae.

Entities:  

Mesh:

Year:  2010        PMID: 20186945     DOI: 10.1002/ibd.21228

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  23 in total

Review 1.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

Review 2.  Imaging techniques and combined medical and surgical treatment of perianal Crohn's disease.

Authors:  F Botti; A Losco; C Viganò; B Oreggia; M Prati; E Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-24

3.  Sphincter-sparing intersphincteric rectal resection as an alternative to proctectomy in long-standing fistulizing and stenotic Crohn's proctitis?

Authors:  Nicolas Schlegel; Mia Kim; Joachim Reibetanz; Katica Krajinovic; Christoph-Thomas Germer; Christoph Isbert
Journal:  Int J Colorectal Dis       Date:  2015-04-08       Impact factor: 2.571

Review 4.  Prevention and management of nonhealing perineal wounds.

Authors:  Allen Kamrava; Najjia N Mahmoud
Journal:  Clin Colon Rectal Surg       Date:  2013-06

5.  Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.

Authors:  Britta Siegmund; Roger M Feakins; Giorgos Barmias; Juliano Coelho Ludvig; Fabio Vieira Teixeira; Gerhard Rogler; Michael Scharl
Journal:  J Crohns Colitis       Date:  2015-12-17       Impact factor: 9.071

Review 6.  Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.

Authors:  Ricardo Sordo-Mejia; Wolfgang B Gaertner
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 7.  Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.

Authors:  Julián Panés; Jordi Rimola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-09       Impact factor: 46.802

Review 8.  Epithelial-mesenchymal transition in Crohn's disease.

Authors:  H Jiang; J Shen; Z Ran
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

9.  Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.

Authors:  Conrado Martinez-Cadenas; Nuria Bosch; Lucas Peñas; Esther Flores-Couce; Enrique Ochoa; Javier Munárriz; Juan P Aracil; Marcos Tajahuerce; Ramón Royo; Rafael Lozoya; Enrique Boldó
Journal:  BMC Cancer       Date:  2011-08-09       Impact factor: 4.430

10.  Anal adenocarcinoma complicating chronic Crohn's disease.

Authors:  Ioannis Papaconstantinou; Dionysios S Mantzos; Agathi Kondi-Pafiti; Ioannis E Koutroubakis
Journal:  Int J Surg Case Rep       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.